Moderna, Inc.
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna Actual returns/credits applied related to prior-period by Quarter
Actual returns/credits applied related to prior-period sales ($M) ($M)
Moderna Actual returns/credits applied related to prior-period: $26M in Q2 2026, unchanged from a year earlier.
Where the Q2 2026 figure comes from
Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)
Source: Form 10-Q (filed 2026-07-31) ↗
Reported in Form 10-Q / 10-K Note 2 (Sales Returns Reserve Rollforward).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Actual returns/credits applied related to prior-period sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 26 | 0.0% | Form 10-Q (filed 2026-07-31) ↗ |
| Q1 2026 | Mar 31, 2026 | 48 | +60.0% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | 119 | -10.5% | Form 10-K (filed 2026-02-20) ↗ |
| Q3 2025 | Sep 30, 2025 | 107 | -49.8% | Form 10-Q (filed 2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 26 | -27.8% | Form 10-Q (filed 2025-08-01) ↗ |
| Q1 2025 | Mar 31, 2025 | 30 | +100.0% | Form 10-Q (filed 2025-05-01) ↗ |
| Q4 2024 | Dec 31, 2024 | 133 | – | Form 10-K (filed 2025-02-21) ↗ |
| Q3 2024 | Sep 30, 2024 | 213 | – | Form 10-Q (filed 2024-11-07) ↗ |
| Q2 2024 | Jun 30, 2024 | 36 | – | Form 10-Q (filed 2024-08-01) ↗ |
| Q1 2024 | Mar 31, 2024 | 15 | – | Form 10-Q (filed 2024-05-02) ↗ |
Cite this data
StockData. (2026). Moderna Actual returns/credits applied related to prior-period ($M), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/gtn-returns-paid-prior
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.